# PANTOPRAZOLE SODIUM
> **ANDA217416** · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2023-02-09
## Drug
- **FDA Application Number:** ANDA217416
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PANTOPRAZOLE SODIUM
- **Generic name:** PANTOPRAZOLE SODIUM
- **Active ingredients:** PANTOPRAZOLE SODIUM
- **Dosage form:** FOR SUSPENSION, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AJANTA PHARMA LTD
- **Manufacturer:** Ajanta Pharma USA Inc.
- **First approval:** 2023-02-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217416)
---
*AI Analytics · CC0 1.0*